Strattera for adderall withdrawal

Strattera for adderall withdrawal

Atomoxetine works in the brain to increase attention and decrease restlessness in people who are hyperactive, have problems with concentration, or are easily distracted. This medicine may be used as part of a treatment program that includes social, educational, and psychologic treatment. Overview: Atomoxetine is used to help with attention deficit and hyperactivity disorder (ADHD) by improving focus and reducing impulsivity and hyperactivity. It works by increasing a natural. Easy-to-read patient tips for Strattera covering how it works, benefits, risks, and best practices. Strattera is used to treat ADHD in adults and some children. Find out its recommended dosages, how to take it, and more. Strattera (atomoxetine) is a non-stimulant ADHD medication. Learn side effects, uses, dosages, and warnings. Strattera is a non-stimulant medication that is used to treat ADHD in children and adults. Learn more about the pros and cons of taking Strattera. Atomoxetine is a prescription medication that is used to treat attention-deficit hyperactivity disorder (ADHD). Symptoms of ADHD interfere can affect a person’s ability to function at school, work or in social settings. Symptoms can include: Hyperactivity is less common in adults. Strattera is a treatment for attention deficit hyperactivity disorder (ADHD) to help improve attention and reduce hyperactivity and impulsiveness. Strattera works by increasing levels of norepinephrine, a chemical messenger in the brain that is involved in hyperactivity and impulse control. Atomoxetine is manufactured, marketed, and sold in the United States as the hydrochloride salt (atomoxetine HCl) under the brand name Strattera by Eli Lilly and Company, the original patent -filing company and current U.S. patent owner. Strattera is approved for the treatment of attention- deficit/hyperactivity disorder (ADHD) in children aged 6 and older, teens, and adults.older, teens, and adults.

Leave a Reply

Your email address will not be published. Required fields are marked *

*
*